These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 21217185)

  • 1. High Prevalence of Echocardiographic Abnormalities among HIV-infected Persons in the Era of Highly Active Antiretroviral Therapy.
    Mondy KE; Gottdiener J; Overton ET; Henry K; Bush T; Conley L; Hammer J; Carpenter CC; Kojic E; Patel P; Brooks JT;
    Clin Infect Dis; 2011 Feb; 52(3):378-86. PubMed ID: 21217185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy.
    Grau I; Pallares R; Tubau F; Schulze MH; Llopis F; Podzamczer D; Liñares J; Gudiol F;
    Arch Intern Med; 2005 Jul; 165(13):1533-40. PubMed ID: 16009870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular disease and HIV infection: host, virus, or drugs?
    Martínez E; Larrousse M; Gatell JM
    Curr Opin Infect Dis; 2009 Feb; 22(1):28-34. PubMed ID: 19532078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
    Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
    J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study.
    Friis-Møller N; Weber R; Reiss P; Thiébaut R; Kirk O; d'Arminio Monforte A; Pradier C; Morfeldt L; Mateu S; Law M; El-Sadr W; De Wit S; Sabin CA; Phillips AN; Lundgren JD;
    AIDS; 2003 May; 17(8):1179-93. PubMed ID: 12819520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-terminal pro-B-type natriuretic peptide (NT-proBNP) in HIV-1 infected individuals on HAART.
    Berg T; Zdunek D; Stalke J; Dupke S; Baumgarten A; Carganico A; Hess G
    Eur J Med Res; 2007 Apr; 12(4):152-60. PubMed ID: 17509959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular disease and toxicities related to HIV infection and its therapies.
    Zareba KM; Miller TL; Lipshultz SE
    Expert Opin Drug Saf; 2005 Nov; 4(6):1017-25. PubMed ID: 16255661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of recurrent nontyphoid Salmonella bacteremia in HIV-infected patients in the era of highly active antiretroviral therapy and an increasing trend of fluoroquinolone resistance.
    Hung CC; Hung MN; Hsueh PR; Chang SY; Chen MY; Hsieh SM; Sheng WH; Sun HY; Huang YT; Lo YC; Hsiao CF; Chang SC
    Clin Infect Dis; 2007 Sep; 45(5):e60-7. PubMed ID: 17682981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [HIV infection, antiretroviral therapy, and endothelium].
    Hürlimann D; Weber R; Enseleit F; Lüscher TF
    Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First Italian consensus statement on diagnosis, prevention and treatment of cardiovascular complications in HIV-infected patients in the HAART era (2006).
    Carosi G; Quiros-Roldan E; Torti C; Antinori A; Bevilacqua M; Bonadonna RC; Bonfanti P; Castagna A; Cauda R; d'Arminio-Monforte A; Di Gregorio P; Di Perri G; Esposito R; Fatuzzo F; Gervasoni C; Giannattasio C; Guaraldi G; Lazzarin A; Lo Caputo S; Maggi P; Mazzotta F; Moroni M; Prestileo T; Ranieri R; Rizzardini G; Russo R; Galli M;
    Infection; 2007 Jun; 35(3):134-42. PubMed ID: 17565453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy.
    European Collaborative Study
    Clin Infect Dis; 2005 Feb; 40(3):458-65. PubMed ID: 15668871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of cardiovascular disease in HIV-infected patients.
    Das S
    J Antimicrob Chemother; 2010 Mar; 65(3):386-9. PubMed ID: 20026610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of premature atherosclerosis and ischemic heart disease associated with HIV infection and antiretroviral therapy.
    Calza L; Manfredi R; Pocaterra D; Chiodo F
    J Infect; 2008 Jul; 57(1):16-32. PubMed ID: 18358535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of dyslipidemia associated with Highly Active Antiretroviral Therapy (HAART) on cardiovascular risk and life expectancy.
    Grover SA; Coupal L; Gilmore N; Mukherjee J
    Am J Cardiol; 2005 Mar; 95(5):586-91. PubMed ID: 15721096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved survival of persons with human immunodeficiency virus type 1 infection in the era of highly active antiretroviral therapy in Taiwan.
    Hung CC; Hsiao CF; Chen MY; Hsieh SM; Chang SY; Sheng WH; Sun HY; Chang SC
    Jpn J Infect Dis; 2006 Aug; 59(4):222-8. PubMed ID: 16936339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
    Bonnet F; Lewden C; May T; Heripret L; Jougla E; Bevilacqua S; Costagliola D; Salmon D; Chêne G; Morlat P
    Cancer; 2004 Jul; 101(2):317-24. PubMed ID: 15241829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The basis and management of metabolic abnormalities associated with cardiovascular risk in human immunodeficiency virus infection and its treatment.
    Crook M
    Ann Clin Biochem; 2007 May; 44(Pt 3):219-31. PubMed ID: 17456292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral manifestations in human immunodeficiency virus infected children in highly active antiretroviral therapy era.
    dos Santos Pinheiro R; França TT; Ribeiro CM; Leão JC; de Souza IP; Castro GF
    J Oral Pathol Med; 2009 Sep; 38(8):613-22. PubMed ID: 19614862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dyslipidaemia and cardiovascular risk in HIV infection.
    Kulasekaram R; Peters BS; Wierzbicki AS
    Curr Med Res Opin; 2005 Nov; 21(11):1717-25. PubMed ID: 16307691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreasing incidence of herpes zoster in the highly active antiretroviral therapy era.
    Moanna A; Rimland D
    Clin Infect Dis; 2013 Jul; 57(1):122-5. PubMed ID: 23487391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.